C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/04 (2006.01) A61K 31/502 (2006.01) A61K 31/5025 (2006.01) C07D 403/04 (2006.01) C07D 471/04 (2006.01)
Patent
CA 2524622
The present invention provides a compound of formula (I): in which Ar and R1 are phenyl or a heteroaromatic group, R2 is generally hydrogen, R3 is hydrogen or alkyl and X, Y and Z are generally CH or N as VR-1 antagonists; or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising it; its use in therapy; use of it to manufacture medicaments to treat pain or inflammation; and methods of treating pain or inflammation.
Composé de formule (I) dans laquelle Ar et R?1¿ représentent phényle ou un groupe hétéroaromatique, R?2¿ représente généralement hydrogène, R?3¿ représente hydrogène ou alkyle et X, Y et Z représentent généralement CH ou N, en tant qu'antagonistes de VR-1, ou sel acceptable sur le plan pharmaceutique dudit composé, compositions pharmaceutiques contenant ce composé, son utilisation en thérapie, son utilisation pour produire des médicaments destinés à traiter la douleur ou l'inflammation et méthodes de traitement de la douleur ou de l'inflammation.
Blurton Peter
Burkamp Frank
Fletcher Stephen Robert
Jones Brian A.
Mciver Edward Giles
Merck Sharp & Dohme Limited
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Substituted-1-phthalazinamines as vr-1 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted-1-phthalazinamines as vr-1 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted-1-phthalazinamines as vr-1 antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1487427